Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1359 studies found for:    "Hepatitis, Chronic"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
"Hepatitis, Chronic" (1359 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine
2 Unknown † Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
3 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
Conditions: Liver Diseases;   Hepatitis, Chronic;   Hepatitis, Viral, Human;   Hepatitis;   Virus Diseases;   Digestive System Diseases;   Hepatitis B, Chronic;   Hepatitis B;   DNA Virus Infections
Intervention:
4 Active, not recruiting Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, Chronic
Intervention:
5 Terminated Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine
Condition: Hepatitis, Chronic
Interventions: Drug: Lamivudine;   Drug: Telbivudine
6 Recruiting The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
Conditions: Chronic Hepatitis;   Chronic Hepatitis C;   Chronic Alcoholic Hepatitis
Intervention: Drug: High dose vitamin C
7 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
8 Completed Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Peginterferon alfa-2a
9 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
10 Unknown † HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Oral HDV-Interferon + ribavarin;   Drug: Injectable HDV-Interferon + ribavarin
11 Completed An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated-Interferon-alfa-2a
12 Unknown † Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition: Chronic Hepatitis C
Intervention: Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
13 Completed Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
Condition: Chronic Hepatitis C
Intervention: Drug: Amantadine
14 Completed Long-Term Therapy With Ribavirin for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Ribavirin
15 Unknown † Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
16 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
17 Completed Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
Condition: Chronic Hepatitis C
Interventions: Drug: pegylated interferon alpha2a;   Drug: ribavirin
18 Terminated Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Procedure: Blood sampling of peripheral blood mononuclear cells;   Procedure: Blood draw, 20ml peripheral blood mononuclear cells
19 Completed Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
20 Completed Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection
Condition: Chronic Hepatitis C
Intervention: Drug: KRN7000
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years